<DOC>
	<DOC>NCT01811797</DOC>
	<brief_summary>This is a prospective, randomized, double-blind clinical study comparing safety and efficacy of the treatments performed with the Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) device - "Renova" on symptomatic ED patients to the safety and efficacy of the control sham patients.</brief_summary>
	<brief_title>Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Good general health Vascular ED for at least 6 months International Index of Erectile Function 6 (IIEFEF) between 11 to 25 Positive response to PDE5I (able to penetrate on demand=Responders) Negative response to PDE5I (unable to penetrate on demand even with maximum PDE5I dosage = Nonresponders) Stable heterosexual relationship for more than 3 months Hormonal, neurological or psychological pathology Past radical prostatectomy or extensive pelvic surgery Recovering from cancer during last 5 years Any unstable medical, psychiatric, spinal cord injury and penile anatomical abnormalities Clinically significant chronic hematological disease Antiandrogens, oral or injectable androgens Past radiotherapy treatment of the pelvic region International normalized ratio (INR) &gt; 3 for patients using blood thinners (such as Coumadin)</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Extracorporeal shockwave</keyword>
	<keyword>Low intensity shockwaves</keyword>
</DOC>